Press release
Metagenomics Market Anticipated to Reach $2.32 Billion in 2025 and $4 Billion in 2029: In-Depth Analysis on Market Size, CAGR, Key Drivers, and Trends
Metagenomics Global Market Report 2025
What Is The Projected Market Size Of The Global Metagenomics Market And Its Growth Rate?
The global metagenomics market has witnessed significant growth in recent years. Key market statistics include:
- The market size grew from $2.01 billion in 2024 to an estimated $2.32 billion in 2025.
- This represents a compound annual growth rate (CAGR) of 15.4%.
- The market is predicted to reach $4 billion in 2029, growing at a CAGR of 14.7%.
What Is Driving The Growth In The Metagenomics Market?
The rise in the incidence of infectious diseases is significantly contributing to the growth of the metagenomics market. Infectious diseases, also known as transmissible diseases, refer to illnesses caused by pathogenic microorganisms, including bacteria, viruses, fungi, and parasites, and can be transmitted between individuals or through various modes of transmission. Metagenomics offers a means to study infectious diseases by examining the genetic material of associated microbial communities, providing insights into their composition, genetic diversity, and possible interactions. For instance, in February 2024, a report published by the UK Health Security Agency indicated a 10.7% increase in Tuberculosis (TB) cases in England in 2023, with 4,850 cases reported compared to 4,380 in 2022. This increasing prevalence of infectious diseases is a key driver for the growth of the metagenomics market.
Request A Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10815&type=smp
Who Are the Key Players Driving Metagenomics Market Growth?
The key players operating in the metagenomics market include:
- Illumina Inc.
- Promega Corporation
- Qiagen N.V.
- Thermo Fisher Scientific Inc.
- Perkin Elmer Inc.
- Bio-Rad Laboratories Inc.
- F. Hoffmann-La Roche Ltd.
- Novogene Co. Ltd.
- Oxford Nanopore Technologies Limited
- BGI Group
- Eurofins Scientific SE
- Arc Bio LLC
- Computomics GmbH
- Enterome Bioscience
- TAKARA BIO INC.
- Danaher Corporation
- ELITechGroup
- Metagenomi
- Cosmosid Inc.
- Pattern Ag
- Tiny Health
- MATIS OHF
- Adapsyn Bioscience
- Precidiag Inc.
- One Codex Inc.
- MetaBi Inc.
- Zymo Research Corporation
- Bluebee Holding BV
- Maverix Biomics Inc.
- Lucigen Corporation
What Are The Key Trends In The Metagenomics Market?
The forecast period for the metagenomics market is expected to see the following trends:
- Technological advancements in sequencing
- Integration of artificial intelligence and machine learning
- Development of single-cell metagenomics
- Standardization of metagenomic data
- Growth in consumer wellness and personalized nutrition
What Are The Segments Of The Global Metagenomics Market?
The metagenomics market is segmented by:
- Product: Instruments, Kits And Reagents, Software And Services
- Workflow: Sequencing, Pre-Sequencing, Data Analysis
- Application: Environmental, Clinical Diagnostics, Drug Discovery, Biotechnology, Food And Nutrition, Other Applications
- End User: Pharmaceutical Industries, Research Laboratories, Biotechnology Companies, Pathology Laboratories, Academic And Research Institutes
Which Region Leads The Metagenomics Market?
North America held the largest share of the global metagenomics market in 2024. However, Asia-Pacific is expected to witness the fastest growth in the forecast period. The regions covered in the metagenomics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Pre-book the report for swift delivery:
https://www.thebusinessresearchcompany.com/report/metagenomics-global-market-report
What Is Covered In The Metagenomics Global Market Report?
- Market Size Analysis: Analyze the Metagenomics market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Metagenomics market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Metagenomics market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Metagenomics Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Request Customization for This Report:
https://www.thebusinessresearchcompany.com/Customise?id=10815&type=smp
About The Business Research Company:
The Business Research Company has over 15,000+ reports from 27 industries covering 60+ geographies, having built a reputation for offering comprehensive, data-rich research and insights. They have 1,500,000 datasets, providing in-depth secondary research, and unique insights from industry leaders, thereby delivering the information you need to stay ahead. Their flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact The Business Research Company:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Connect with us on
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Metagenomics Market Anticipated to Reach $2.32 Billion in 2025 and $4 Billion in 2029: In-Depth Analysis on Market Size, CAGR, Key Drivers, and Trends here
News-ID: 3831028 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Metagenomi
Cell Engineering Service Market Set to Grow Steadily Through 2025, Key Trends, R …
QY Research has recently published a research report titled, "Global Cell Engineering Service Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031", assessing various factors impacting its trajectory. The research study offers deep evaluation of the global Cell Engineering Service market and helps market participants to gain a strong foothold in the industry. It sheds light on critical market dynamics such as drivers, restraints, trends, and opportunities to help…
2025-2034 Base-Editing Tools Market Evolution: Disruptions, Innovations, and Unt …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Base-Editing Tools Market Through 2025?
In recent times, the market size for base-editing tools has seen a staggering growth. Expected to expand from $1.50 billion in 2024 to $1.83 billion in 2025, it's forecasted to boast a compound annual growth rate (CAGR)…
Long Term Investors in shares of Metagenomi, Inc. (NASDAQ: MGX) should contact t …
An investigation on behalf of current long-term investors in shares of Metagenomi, Inc. (NASDAQ: MGX) concerning potential breaches of fiduciary duties by certain directors and officers of Metagenomi, Inc. was announced.
Investors who are current long term investors in Metagenomi, Inc. (NASDAQ: MGX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term…
Investigation announced for Long Term Investors in shares of Metagenomi, Inc. (N …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Metagenomi, Inc.
Investors who are current long term investors in Metagenomi, Inc. (NASDAQ: MGX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: MGX stocks follows a lawsuit filed against Metagenomi, Inc. over…
Lawsuit filed for Investors who lost money with shares of Metagenomi, Inc. (NASD …
An investor, who purchased shares of Metagenomi, Inc. (NASDAQ: MGX), filed a lawsuit over alleged violations of Federal Securities Laws by Metagenomi, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Metagenomi, Inc. (NASDAQ: MGX) have certain options and for certain investors are short and strict deadlines running. Deadline: November 25, 2024. NASDAQ: MGX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)…
Lawsuit filed for Investors who lost money with Metagenomi, Inc. (NASDAQ: MGX) i …
An investor, who purchased shares of Metagenomi, Inc. (NASDAQ: MGX), filed a lawsuit over alleged violations of Federal Securities Laws by Metagenomi, Inc. in connection with certain allegedly false and misleading statements made between February 9 and 13, 2024.
Investors who purchased a significant amount of shares of Metagenomi, Inc. (NASDAQ: MGX) between February 9 and 13, 2024, have certain options and for certain investors are short and strict deadlines running.…
